Skip to main contentSkip to navigation
Sirius Investors
HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTGMQ
OTCHealthcare

HTG Molecular Diagnostics, Inc. (HTGMQ) Investment Research Dashboard

About HTG Molecular Diagnostics, Inc. (HTGMQ) stock analysis

Get live HTGMQ stock price $0.00, comprehensive HTG Molecular Diagnostics, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HTGMQ stock data and investment insights.

0.00
0.00%Today
Market Cap
221
Volume
125
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applications engineered to automate the processing of sample...

Company Information

CEO
John L. Lubniewski
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
53

Contact Information

Address
3430 East Global Loop
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 2.76)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for HTG Molecular Diagnostics, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for HTG Molecular Diagnostics, Inc.
  • Investors should consider how HTG Molecular Diagnostics, Inc. fits within their overall portfolio allocation

Market Cap

221

Beta

2.76

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

69/100 ⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.6%+2.6%+3.7%19.2
98/100⭐⭐⭐⭐⭐
Consumer Defensive+1.4%+3.5%+2.4%30.2
78/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.1%+1.4%24.0
69/100⭐⭐⭐⭐
Communication Services+0.6%-1.4%+2.2%22.0
67/100⭐⭐⭐⭐
Basic Materials+0.7%+1.5%+0.0%25.2
66/100⭐⭐⭐⭐
Real Estate+0.2%+0.7%-1.8%29.4
50/100⭐⭐⭐
Energy-0.5%-2.2%-2.6%19.4
41/100⭐⭐⭐
Utilities-0.8%+0.2%-4.2%26.9
36/100⭐⭐
Consumer Cyclical+0.2%-1.8%-6.1%42.6
18/100
Industrials-0.4%-0.6%-10.8%29.8
18/100
Technology-0.7%-2.9%-8.3%40.1
8/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.